[Evidence-based therapy of osteoporosis--comment on DMW 17/2003].
Traut
V
V
D019386:Alendronate / Q000191:economics* / Q000627:therapeutic use; D002017:Budgets / Q000331:legislation & jurisprudence; D016527:Drug Costs / Q000331:legislation & jurisprudence; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000191:economics* / Q000627:therapeutic use; D019317:Evidence-Based Medicine / Q000191:economics*; D005858:Germany; D006801:Humans; D009313:National Health Programs / Q000191:economics*; D010024:Osteoporosis / Q000188:drug therapy / Q000191:economics*; D000068296:Risedronic Acid
D000068296:Risedronic Acid; D012968:Etidronic Acid; D019386:Alendronate